Spain Blackout Investigation Shows EU Grids Need More Resilience
Preliminary findings of an investigation into a wide-ranging blackout in Spain earlier this year show that European power grids need to improve resilience, according to a report from the European Network of Transmission System Operators for Electricity.
The group, known as ENTSO-E, has assembled a panel of experts to pore over data from Spanish grid operators and power producers to find out what exactly happened in April that suddenly caused millions across the country to lose electricity. Preliminary results show that a cascading series of disconnections of electricity generation and unusual voltage increases were the most likely reason for the blackout, according to an update published Wednesday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
When will the next total solar eclipse be visible in the UK?
The sky goes dark, birds fall silent, and a chill comes to the air - there's no question total solar eclipses are the most spectacular event in the celestial calendar. On 2 August, 2027, parts of southern Europe will see a total solar eclipse. It won;t be quite as spectacular in the UK. Londoners will experience a 42% eclipse - with the sun appearing as a crescent. People in the Scilly Isles will see a partial eclipse of 48%, while those in the Shetlands will see a 13% eclipse. In a partial eclipse, the sky will not go dark, but shadows might look different, and the sun is visibly 'blocked' by the moon - while a total eclipse offers a few minutes of darkness which often provokes audible gasps. The total eclipse will see areas such as the Straits of Gibraltar, North Africa and the Arabian Peninsula, with up to six minutes, 23 seconds of 'totality'. Luxor in Egypt and Mecca in Saudi Arabia are among the areas on the path of totality, according to Sky at Night magazine. Despite online reports this week, which possibly mixed up the events in 2027, there is most definitely no eclipse in August 2025 - the only eclipse this year came earlier, when the UK saw a partial eclipse with up to 30% eclipse on 29 March 2025. When will the next total solar eclipse be in the UK? Next year will see a partial eclipse on 12 August, 2026, with the eclipse peaking at 96% in the Scilly Isles. Most areas in the UK will see an 89% eclipsed sun. But if you're waiting for a proper total solar eclipse in the UK, you're in for rather a long wait (and it will also help to be young at this point) as the next one will not be until 23 September, 2090, when it will be visible from southern England and southern Ireland. What happens during a total solar eclipse? Total solar eclipses happen when the moon completely covers the sun, and is only visible from a certain area (known as 'the path of totality'). Areas nearby witness a partial eclipse instead. The reason it happens is that the moon is 400 times smaller than the sun, and also 400 times closer to us than the Sun (by complete coincidence), so that they appear 'the same size' at the time of an eclipse. In the darkest part of the shadow, the Sun's light is almost completely blocked out. NASA says, 'People viewing the eclipse from locations where the Moon's shadow completely covers the Sun – known as the path of totality – will experience a total solar eclipse. The sky will become dark, as if it were dawn or dusk. 'Weather permitting, people along the path of totality will see the Sun's corona, or outer atmosphere, which is usually obscured by the bright face of the Sun.' Some observers report feeling a chill, and birds stopping singing because they think it's night time. The last total solar eclipse in the UK was in 1999, although it was only visible from Cornwall and the Scilly isles, according to the Royal Observatory. Patchy weather meant that only some eclipse-watchers got a good sight of the eclipse (and some were soaked with rain instead). The Guardian describes how 'gasps of amazement' rang out in Penzance as totality descended for two minutes and six seconds.
Yahoo
an hour ago
- Yahoo
New tool can predict which children are likely to become obese
Scientists have developed a new tool which can predict a child's risk of becoming obese in adulthood. The test could help to identify children and adolescents who would benefit from targeted preventative strategies, like diet and exercise, at a younger age. The new test, which analyses DNA from a blood sample, is thought to be twice as effective at predicting obesity as the previous best test. As well as identifying children at risk of obesity, it can also predict how well obese adults will respond to targeted weight loss programmes. 'What makes the score so powerful is its ability to predict, before the age of five, whether a child is likely to develop obesity in adulthood, well before other risk factors start to shape their weight later in childhood. Intervening at this point can have a huge impact,' said Assistant Professor Roelof Smit from the University of Copenhagen and lead author of the research published in the journal Nature Medicine. Obesity is a major and chronic problem around the world that is only growing. A disease characterized by excessive fat accumulation, people with obesity are also more likely to have numerous health conditions, including type 2 diabetes and high blood pressure. The World Obesity Federation expects more than half the global population to become overweight or obese by 2035. A groundbreaking new tool from international researchers aims to predict future obesity during childhood. Tens of millions are affected by the chronic condition around the world (Getty/iStock) In England, almost 65 per cent of adults over the age of 18 are overweight or obese, while around one in eight children aged between two and 10 in England are obese, according to the NHS. In the U.S., some two in five adults and one in five children and adolescents have obesity. The Centers for Disease Control and Prevention says it affects some groups more than others, including non-Hispanic Black adults and adults with less education. Although there are ways of tackling obesity, such as through diet, exercise, surgery and medication, these options are not always available and do not work for everyone. Research for the study involved a collaboration with the consumer genetics and research company 23andMe, and the contributions of more than 600 scientists from 500 institutions globally. Traits such as human height and body mass index were noted and gathered in the data. Subtle variations in our genetics can impact our health, including the likelihood of developing obesity and even our appetite, experts say. Scientists drew on the genetic data of more than five million people – the largest and most diverse genetic dataset ever (Getty/iStock) Thousands of genetic variants have been identified that increase the risk of obesity, influencing appetite. To determine a child's future risk of obesity, the researchers developed a scoring system, known as a 'polygenic risk score.' To score patients, the new system adds the effects of these risk variants up. The researchers said it was able to explain nearly a fifth of a person's variation in body mass index. To create the score, the scientists drew on the genetic data of more than five million people – the largest and most diverse genetic dataset ever. They then tested the new risk score for obesity on datasets of the physical and genetic characteristics of more than 500,000 people. "This new polygenic score is a dramatic improvement in predictive power and a leap forward in the genetic prediction of obesity risk, which brings us much closer to clinically useful genetic testing," said Professor Ruth Loos from CBMR at the University of Copenhagen. It assessed the relationship between a person's genetic risk of obesity and the impact of lifestyle interventions, such as diet and exercise. Scientists found that those with a higher genetic risk of obesity were more responsive to interventions, but they also gained weight quickly once those interventions ended. However, the new test does have its limitations. Despite drawing on the genetics of the global population, it was far better at predicting obesity in people with European ancestry than in people with African ancestry.
Yahoo
an hour ago
- Yahoo
Life sciences VC Omega Funds closes $647m funding round
Life sciences venture capital (VC) company Omega Funds has closed its eighth fund, with capital commitments totalling $647m. As with its previous funds, the US-based business said its oversubscribed funding, which had initially targeted a $600m close, will continue executing on its strategy to support management teams in the US and Europe that target severe, unmet medical needs through company creation, early venture rounds, and later-stage financing. Omega Funds managing director Francesco Draetta said: 'We believe our broad investment strategy is well-positioned for navigating this period of macro and policy uncertainty. 'We look forward to contributing our capital, expertise, and network connectivity in partnering with entrepreneurs, founders, co-investors, and the broader community to transform the standards of care for severe diseases.' According to Omega, it has raised $2.5bn since its first fund in 2004 to support the development of medical devices and therapeutics across indications including oncology, immunology, and rare diseases. In total, 52 products have been brought to market by Omega's former portfolio companies, with the VC's previous investments resulting in 50 exits via M&A, and 47 public listings. M&A exits include SoniVie, Scorpion Therapeutics, and Amunix Pharmaceuticals, which were acquired by Boston Scientific, Eli Lilly, and Sanofi, respectively. Companies that Omega has invested in have gone on to launch initial public offerings (IPO). These include Kestra Medical Technologies, Beta Bionics, and Imago Biosciences, all of which are listed on the Nasdaq exchange. Omega Funds' founder and managing director Otello Stampacchia commented: 'By exceeding its target size, fund VIII is a recognition of our investment strategy and track record of consistent exits across market cycles.' Life science companies are typically reliant on investment from VC or private equity (PE) businesses. While research by Bain & Company found that deal value in 2023 struggled to match the pace of previous years, more recent research by the consultant found that healthcare PE soared to an estimated $115bn in 2024, making it the second-highest deal value total on record. Other significant entities backing life science companies include Symbiotic Capital. The credit company from biotech entrepreneur Arie Belldegrun, founder of Kite Pharma and co-founder of Bellco Capital, launched in August 2024 with $600m for life science-specific loans. "Life sciences VC Omega Funds closes $647m funding round" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
